Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enliven Treateutics

23.00
+0.55002.45%
Post-market: 23.000.00000.00%16:20 EDT
Volume:416.24K
Turnover:9.52M
Market Cap:1.32B
PE:-11.90
High:23.24
Open:22.41
Low:21.80
Close:22.45
Loading ...
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Apr 27, 2024

Correspondence

Form CORRESP - Correspondence
Apr 19, 2024

Correspondence

Form CORRESP - Correspondence
Apr 15, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2024

Major Issues Report

Form 8-K - Current report
Apr 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]